We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
(-4%)
Cap. Flow
-$2.79B
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$66.4M |
| 2 |
Valero Energy
VLO
|
+$28.9M |
| 3 |
SLB Ltd
SLB
|
+$24.8M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$22.6M |
| 5 |
PepsiCo
PEP
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$90.9M |
| 4 |
Amgen
AMGN
|
+$72.1M |
| 5 |
Tesla
TSLA
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.26% |
| 2 | Technology | 28.78% |
| 3 | Financials | 8.15% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Donnelley Financial Solutions
DFIN
$1.21B
| – | – |
-71,489
| Closed | -$2.69M |
|
|
DOCU
727
DocuSign
DOCU
$9.63B
| – | – |
-53,187
| Closed | -$2.85M |
|
728
Descartes Systems
DSGX
$5.84B
| – | – |
-4,778
| Closed | -$354K |
|
729
Dynatrace
DT
$12.1B
| – | – |
-12,161
| Closed | -$473K |
|
730
DaVita
DVA
$15.1B
| – | – |
-9,121
| Closed | -$681K |
|
731
Elanco Animal Health
ELAN
$12.4B
| – | – |
-24,041
| Closed | -$208K |
|
732
Equity Lifestyle Properties
ELS
$12.8B
| – | – |
-9,959
| Closed | -$615K |
|
733
Enovis
ENOV
$1.56B
| – | – |
-8,506
| Closed | -$419K |
|
734
Enanta Pharmaceuticals
ENTA
$372M
| – | – |
-40,507
| Closed | -$1.51M |
|
735
Entegris
ENTG
$19.7B
| – | – |
-8,395
| Closed | -$634K |
|
|
ESGR
736
DELISTED
Enstar Group
ESGR
| – | – |
-15,302
| Closed | -$3.26M |
|
737
FuelCell Energy
FCEL
$1.7B
| – | – |
-53,521
| Closed | -$4.21M |
|
738
FTI Consulting
FCN
$4.82B
| – | – |
-26,152
| Closed | -$4.75M |
|
739
F5
FFIV
$22.1B
| – | – |
-3,401
| Closed | -$456K |
|
740
First Horizon
FHN
$12.1B
| – | – |
-103,398
| Closed | -$1.69M |
|
741
FMC
FMC
$1.42B
| – | – |
-6,323
| Closed | -$711K |
|
742
Fidelity National Financial
FNF
$13.9B
| – | – |
-14,563
| Closed | -$468K |
|
743
FirstService
FSV
$6.32B
| – | – |
-2,415
| Closed | -$313K |
|
744
Fulcrum Therapeutics
FULC
$248M
| – | – |
-101,337
| Closed | -$266K |
|
745
GATX Corp
GATX
$6.55B
| – | – |
-20,049
| Closed | -$2.03M |
|
|
TDAY
746
USA Today Co
TDAY
$1.23B
| – | – |
-210,938
| Closed | -$363K |
|
747
Graco
GGG
$12.9B
| – | – |
-9,493
| Closed | -$638K |
|
748
Gildan
GIL
$9.25B
| – | – |
-32,175
| Closed | -$983K |
|
749
Globe Life
GL
$13.5B
| – | – |
-6,703
| Closed | -$679K |
|
750
Genmab
GMAB
$17.7B
| – | – |
-106,291
| Closed | -$3.69M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2023 Portfolio in Review
As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.
- Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
- Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
- Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
- Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
- Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
- Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
- Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.
Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.